UBS Downgrades BHEL to Neutral But Raises Target to ₹460

UBS downgraded BHEL from Buy to Neutral while simultaneously raising its target price from ₹375 to ₹460 implying 13% upside. The seemingly contradictory move downgrade but higher target reflects a stock that has performed brilliantly but now faces a tougher road ahead. Stock already outperformed massively BHEL outperformed Nifty by 60% over the last 12 months. Most of the good news is already priced in there is limited incremental upside from here even if the business continues doing well. Competition is intensifying L&T and Thermax are showing greater appetite for orders in BHEL's core thermal and industrial segments. Three years ago BHEL had 75-80% market share but that dominance is now being challenged by private sector rivals with faster execution and better technology. Bulk of order book expansion is behind BHEL's order book grew massively but UBS believes the peak of that expansion cycle is now over. Future order wins will be harder to come by as competition increases. UBS still believes $BHEL BHEL's business is strong and raised earnings estimates for FY27 and FY28. So the target price went up from ₹375 to ₹460. But since the stock has already rallied so much the gap between current price and target price is now only 13%. That limited upside no longer justifies a Buy rating hence the downgrade to Neutral. UBS's simultaneous downgrade and target price hike on BHEL taught me that a great business and a great stock are not always the same thing, and that when companies like BHEL outperform the market by 60% in a year the risk reward shifts making it essential to evaluate not just business quality but also how much growth is already priced into the stock before investing in PSU infrastructure companies like BHEL, $LT L&T and $THERMAX Thermax.